New biomarkers for improved treatment of severe heart- and lung disease

New blood biomarkers reflecting vasoreactivity in lung blood vessels of patients with heart- and lung disease, can lead to simplified diagnostics and better evaluation of treatment for patients with the condition pulmonary arterial hypertension (PAH), a new dissertation suggests. —> Read More